Andre Pascale

Person

Marseille, FR

People

Patents Grantslast 30 patents

Information Patent Grant
Treatment regimens using anti-NKG2A antibodies
- Patent number 12,037,392
- Issue date Jul 16, 2024
- Innate Pharma
- Pascale Andre
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neutralization of inhibitory pathways in lymphocytes
- Patent number 11,572,410
- Issue date Feb 7, 2023
- Innate Pharma
- Pascale Andre
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancers using anti-NKG2A agents
- Patent number 11,225,519
- Issue date Jan 18, 2022
- Innate Pharma
- Pascale Andre
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neutralization of inhibitory pathways in lymphocytes
- Patent number 10,870,700
- Issue date Dec 22, 2020
- Innate Pharma
- Pascale Andre
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Neutralization of inhibitory pathways in lymphocytes
- Patent number 10,711,063
- Issue date Jul 14, 2020
- Innate Pharma
- Pascale Andre
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer
- Patent number 10,688,180
- Issue date Jun 23, 2020
- Bristol-Myers Squibb Company
- Robert F. Graziano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment regimens using anti-NKG2A antibodies
- Patent number 10,676,523
- Issue date Jun 9, 2020
- Innate Pharma
- Pascale Andre
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination of anti-KIR and anti-CS1 antibodies to treat multiple m...
- Patent number 10,494,433
- Issue date Dec 3, 2019
- Bristol-Myers Squibb Company
- Pascale Andre
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of cancers using anti-NKG2A agents
- Patent number 10,329,348
- Issue date Jun 25, 2019
- Innate Pharma
- Pascale Andre
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal antibodies against NKG2A
- Patent number 10,160,810
- Issue date Dec 25, 2018
- Innate Pharma, S.A.
- Alessandro Moretta
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for treatment of recurrent hematological malignancies
- Patent number 9,844,593
- Issue date Dec 19, 2017
- Innate Pharma S.A.
- Pascale Andre
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer
- Patent number 9,789,182
- Issue date Oct 17, 2017
- Bristol-Myers Squibb Company
- Robert F. Graziano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-KIR antibodies for the treatment of inflammatory and autoimmun...
- Patent number 9,067,997
- Issue date Jun 30, 2015
- Innate Pharma S.A.
- Francois Romagne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal antibodies against NKG2A
- Patent number 8,993,319
- Issue date Mar 31, 2015
- Innate Pharma S.A.
- Alessandro Moretta
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human anti-KIR antibodies
- Patent number 8,981,065
- Issue date Mar 17, 2015
- Novo Nordisk A/S Novo allé
- Alessandro Moretta
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for regulating NK cell activity
- Patent number 8,637,258
- Issue date Jan 28, 2014
- Novo Nordisk A/S
- Soren Berg Padkjaer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nucleic acids encoding human anti-kir antibodies
- Patent number 8,614,307
- Issue date Dec 24, 2013
- Novo-Nordisk A/S—Novo Alle
- Alessandro Moretta
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Human anti-KIR antibodies
- Patent number 8,119,775
- Issue date Feb 21, 2012
- University of Genoa
- Alessandro Moretta
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES
- Publication number 20240368281
- Publication date Nov 7, 2024
- Innate Pharma
- PASCALE ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES
- Publication number 20230303691
- Publication date Sep 28, 2023
- Innate Pharma
- PASCALE ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES
- Publication number 20230235060
- Publication date Jul 27, 2023
- Innate Pharma
- PASCALE ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES
- Publication number 20210238285
- Publication date Aug 5, 2021
- Innate Pharma
- PASCALE ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES
- Publication number 20210122821
- Publication date Apr 29, 2021
- Innate Pharma
- PASCALE ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES
- Publication number 20200332008
- Publication date Oct 22, 2020
- Innate Pharma
- PASCALE ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES
- Publication number 20200299383
- Publication date Sep 24, 2020
- Innate Pharma
- PASCALE ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCERS USING ANTI-NKG2A AGENTS
- Publication number 20190322744
- Publication date Oct 24, 2019
- Innate Pharma
- PASCALE ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES
- Publication number 20190031755
- Publication date Jan 31, 2019
- Innate Pharma
- PASCALE ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF ANTI-KIR AND ANTI-CTLA-4 ANTIBODIES TO TREAT CANCER
- Publication number 20180117147
- Publication date May 3, 2018
- Bristol-Myers Squibb Company
- Robert F. GRAZIANO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCERS USING ANTI-NKG2A AGENTS
- Publication number 20170313773
- Publication date Nov 2, 2017
- Innate Pharma
- PASCALE ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES
- Publication number 20170298131
- Publication date Oct 19, 2017
- Innate Pharma
- PASCALE ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES
- Publication number 20170291947
- Publication date Oct 12, 2017
- Innate Pharma
- PASCALE ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF ANTI-KIR AND ANTI-CS1 ANTIBODIES TO TREAT MULTIPLE M...
- Publication number 20160257750
- Publication date Sep 8, 2016
- Bristol-Myers Squibb Company
- Pascale ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-KIR ANTIBODIES FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUN...
- Publication number 20150376275
- Publication date Dec 31, 2015
- Innate Pharma, S.A.
- Francois Romagne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN ANTI-KIR ANTIBODIES
- Publication number 20150344576
- Publication date Dec 3, 2015
- Novo Nordisk A/S - Novo Alle
- Alessandro Moretta
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION OF ANTI-KIR AND ANTI-CTLA-4 ANTIBODIES TO TREAT CANCER
- Publication number 20150283234
- Publication date Oct 8, 2015
- BRISTOL-MYERS SQUIBB COMPANY
- Robert F. Graziano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN ANTI-KIR ANTIBODIES
- Publication number 20150191547
- Publication date Jul 9, 2015
- Novo Nordisk A/S - Novo Alle
- Alessandro Moretta
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MONOCLONAL ANTIBODIES AGAINST NKG2A
- Publication number 20150132316
- Publication date May 14, 2015
- Innate Pharma, S.A.
- ALESSANDRO MORETTA
- G01 - MEASURING TESTING
Information Patent Application
MONOCLONAL ANTIBODIES AGAINST NKG2A
- Publication number 20150125464
- Publication date May 7, 2015
- Innate Pharma, S.A.
- ALESSANDRO MORETTA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR REGULATING NK CELL ACTIVITY
- Publication number 20140193430
- Publication date Jul 10, 2014
- Novo Nordisk A/S
- SØREN BERG PADKJAER
- G01 - MEASURING TESTING
Information Patent Application
HUMAN ANTI-KIR ANITBODIES
- Publication number 20130287770
- Publication date Oct 31, 2013
- Alessandro Moretta
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NK CELL MODULATING TREATMENTS AND METHODS FOR TREATMENT OF HEMATOLO...
- Publication number 20130251711
- Publication date Sep 26, 2013
- INNATE PHARMA SA
- Pascale Andre
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-KIR ANTIBODIES FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUN...
- Publication number 20120328615
- Publication date Dec 27, 2012
- Innate Pharma S.A.
- Francois Romagne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN ANTI-KIR ANTIBODIES
- Publication number 20120208237
- Publication date Aug 16, 2012
- Innate Pharma S.A.S.
- Alessandro Moretta
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Monoclonal Antibodies Against NKG2A
- Publication number 20110229486
- Publication date Sep 22, 2011
- Innate Pharma S.A.
- Allessandro Moretta
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and Methods for Regulating NK Cell Activity
- Publication number 20100291110
- Publication date Nov 18, 2010
- Novo Nordisk A/S
- Søren Berg Padkjaer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MONOCLONAL ANTIBODIES AGAINST NKG2A
- Publication number 20090208416
- Publication date Aug 20, 2009
- Universita Di Genova
- Alessandro Moretta
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and methods for regulating NK cell activity
- Publication number 20090191213
- Publication date Jul 30, 2009
- Novo Nordisk A/S
- Soren Berg Padkjaer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Human Anti-Kir Antibodies
- Publication number 20090081240
- Publication date Mar 26, 2009
- Novo Nordisk A/S
- Alessandro Moretta
- C07 - ORGANIC CHEMISTRY

Andre Pascale

Person

Patents Grantslast 30 patents

Treatment regimens using anti-NKG2A antibodies

Neutralization of inhibitory pathways in lymphocytes

Treatment of cancers using anti-NKG2A agents

Neutralization of inhibitory pathways in lymphocytes

Neutralization of inhibitory pathways in lymphocytes

Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer

Treatment regimens using anti-NKG2A antibodies

Combination of anti-KIR and anti-CS1 antibodies to treat multiple m...

Treatment of cancers using anti-NKG2A agents

Monoclonal antibodies against NKG2A

Methods for treatment of recurrent hematological malignancies

Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer

Anti-KIR antibodies for the treatment of inflammatory and autoimmun...

Monoclonal antibodies against NKG2A

Human anti-KIR antibodies

Compositions and methods for regulating NK cell activity

Nucleic acids encoding human anti-kir antibodies

Human anti-KIR antibodies

Patents Applicationslast 30 patents

TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES

NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES

NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES

TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES

NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES

NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES

TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES

TREATMENT OF CANCERS USING ANTI-NKG2A AGENTS

NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES

COMBINATION OF ANTI-KIR AND ANTI-CTLA-4 ANTIBODIES TO TREAT CANCER

TREATMENT OF CANCERS USING ANTI-NKG2A AGENTS

TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES

NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES

COMBINATION OF ANTI-KIR AND ANTI-CS1 ANTIBODIES TO TREAT MULTIPLE M...

ANTI-KIR ANTIBODIES FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUN...

HUMAN ANTI-KIR ANTIBODIES

COMBINATION OF ANTI-KIR AND ANTI-CTLA-4 ANTIBODIES TO TREAT CANCER

HUMAN ANTI-KIR ANTIBODIES

MONOCLONAL ANTIBODIES AGAINST NKG2A

MONOCLONAL ANTIBODIES AGAINST NKG2A

COMPOSITIONS AND METHODS FOR REGULATING NK CELL ACTIVITY

HUMAN ANTI-KIR ANITBODIES

NK CELL MODULATING TREATMENTS AND METHODS FOR TREATMENT OF HEMATOLO...

ANTI-KIR ANTIBODIES FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUN...

HUMAN ANTI-KIR ANTIBODIES

Monoclonal Antibodies Against NKG2A

Compositions and Methods for Regulating NK Cell Activity

MONOCLONAL ANTIBODIES AGAINST NKG2A

Compositions and methods for regulating NK cell activity

Human Anti-Kir Antibodies